CUSIP: 69833W206
Q1 2023 13F Holders as of 31 Mar 2023
-
Type / Class
-
Equity / COM NEW
-
Total 13F shares
-
1,940,370
-
Share change
-
+1,940,370
-
Total reported value
-
$857,742
-
Price per share
-
$0.44
-
Number of holders
-
19
-
Value change
-
+$857,742
-
Number of buys
-
19
Quarterly Holders Quick Answers
What is CUSIP 69833W206?
CUSIP 69833W206 identifies PBLA - PANBELA THERAPEUTICS INC - COM NEW in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 69833W206:
Institutional Holders of PANBELA THERAPEUTICS INC - COM NEW (PBLA) as of Q1 2023
As of 31 Mar 2023,
PANBELA THERAPEUTICS INC - COM NEW (PBLA) was held by
19 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
1,940,370 shares.
The largest 10 holders included
SABBY MANAGEMENT, LLC, CVI Holdings, LLC, Hudson Bay Capital Management LP, Altium Capital Management LP, Anson Funds Management LP, HRT FINANCIAL LP, STATE STREET CORP, TWO SIGMA SECURITIES, LLC, UBS Group AG, and Warberg Asset Management LLC.
This page lists
19
institutional shareholders reporting positions in this security
for the Q1 2023 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.